Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.
Nat Commun. 2024 May 7;15(1):3805. doi: 10.1038/s41467-024-47514-y.
Nat Commun. 2024.
PMID: 38714664
Free PMC article.
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations.
Balasooriya ER, Wu Q, Ellis H, Zhen Y, Norden BL, Corcoran RB, Mohan A, Martin E, Franovic A, Tyhonas J, Lardy M, Grandinetti KB, Pelham R, Soroceanu L, Silveira VS, Bardeesy N.
Balasooriya ER, et al.
Clin Cancer Res. 2024 May 15;30(10):2181-2192. doi: 10.1158/1078-0432.CCR-23-3588.
Clin Cancer Res. 2024.
PMID: 38437671
Item in Clipboard
Integrating Clinical Cancer and PTM Proteomics Data Identifies a Mechanism of ACK1 Kinase Activation.
Balasooriya ER, Madhusanka D, López-Palacios TP, Eastmond RJ, Jayatunge D, Owen JJ, Gashler JS, Egbert CM, Bulathsinghalage C, Liu L, Piccolo SR, Andersen JL.
Balasooriya ER, et al.
Mol Cancer Res. 2024 Feb 1;22(2):137-151. doi: 10.1158/1541-7786.MCR-23-0153.
Mol Cancer Res. 2024.
PMID: 37847650
Free PMC article.
Item in Clipboard
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma.
Wu Q, Ellis H, Siravegna G, Michel AG, Norden BL, Fece de la Cruz F, Balasooriya ER, Zhen Y, Silveira VS, Che J, Corcoran RB, Bardeesy N.
Wu Q, et al. Among authors: balasooriya er.
Clin Cancer Res. 2024 Jan 5;30(1):198-208. doi: 10.1158/1078-0432.CCR-23-1317.
Clin Cancer Res. 2024.
PMID: 37843855
Free PMC article.
Item in Clipboard
SGK2, 14-3-3, and HUWE1 Cooperate to Control the Localization, Stability, and Function of the Oncoprotein PTOV1.
Pennington KL, McEwan CM, Woods J, Muir CM, Pramoda Sahankumari AG, Eastmond R, Balasooriya ER, Egbert CM, Kaur S, Heaton T, McCormack KK, Piccolo SR, Kurokawa M, Andersen JL.
Pennington KL, et al. Among authors: balasooriya er.
Mol Cancer Res. 2022 Feb;20(2):231-243. doi: 10.1158/1541-7786.MCR-20-1076. Epub 2021 Oct 15.
Mol Cancer Res. 2022.
PMID: 34654719
Free PMC article.
Item in Clipboard
TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth.
Chan TY, Egbert CM, Maxson JE, Siddiqui A, Larsen LJ, Kohler K, Balasooriya ER, Pennington KL, Tsang TM, Frey M, Soderblom EJ, Geng H, Müschen M, Forostyan TV, Free S, Mercenne G, Banks CJ, Valdoz J, Whatcott CJ, Foulks JM, Bearss DJ, O'Hare T, Huang DCS, Christensen KA, Moody J, Warner SL, Tyner JW, Andersen JL.
Chan TY, et al. Among authors: balasooriya er.
Nat Commun. 2021 Sep 9;12(1):5337. doi: 10.1038/s41467-021-25622-3.
Nat Commun. 2021.
PMID: 34504101
Free PMC article.
Item in Clipboard
BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.
Kannangara AR, Poole DM, McEwan CM, Youngs JC, Weerasekara VK, Thornock AM, Lazaro MT, Balasooriya ER, Oh LM, Soderblom EJ, Lee JJ, Simmons DL, Andersen JL.
Kannangara AR, et al. Among authors: balasooriya er.
EMBO Rep. 2021 Oct 5;22(10):e51136. doi: 10.15252/embr.202051136. Epub 2021 Aug 9.
EMBO Rep. 2021.
PMID: 34369648
Free PMC article.
Item in Clipboard
Cite
Cite